Literature DB >> 11182409

Should aminoglycoside antibiotics be abandoned?

W P English1, M D Williams.   

Abstract

BACKGROUND: Aminoglycosides can cause nephrotoxicity and ototoxicity. Alternatives are available.
METHODS: Surgical service antibiotic use, aminoglycoside toxicity, and perioperative culture/sensitivity results from July 1998 to June 1999 were reviewed.
RESULTS: Of 289 positive cultures in 243 patients, 92 cultures (32%) grew 151 Gram-negative rods (GNRs). Aminoglycosides were used in 26 patients and 4 of 26 (15%) suffered nephrotoxicity. Of the 112 GNRs tested against ceftazidime, 111 (99%) were sensitive to it which was significantly better than amikacin (56 of 61, 92%, P = 0.038), gentamicin (116 of 134, 87%, P <0.001), and tobramycin (67 of 81, 83%, P <0.001). The proportion sensitive to cefuroxime (26 of 30, 87%) was equivalent to the proportions sensitive to gentamicin (87%, P = NS) and tobramycin (83%, P = NS). Of the 35 GNRs that were resistant to gentamicin and/or tobramycin, 15 (43%) were Pseudomonas aeruginosa.
CONCLUSION: Aminoglycosides produce a significant rate of nephrotoxicity. There are antibiotics with equal or better sensitivity profiles than aminoglycosides against GNRs and Pseudomonas. Aminoglycoside use is rarely, if ever, indicated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11182409     DOI: 10.1016/s0002-9610(00)00539-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Section 3: Prevention and Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

2.  Frequency and Demographics of Gentamicin Use.

Authors:  Bradley Kushner; Paul D Allen; Benjamin T Crane
Journal:  Otol Neurotol       Date:  2016-02       Impact factor: 2.311

3.  Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.

Authors:  Cedric Charrier; Catherine Rodger; Jennifer Robertson; Aleksandra Kowalczuk; Nicola Shand; Douglas Fraser-Pitt; Derry Mercer; Deborah O'Neil
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.